Clinical Trial Update: Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 study of antiviral cellular therapy intended to enhance T-cell reconstitution around hematopoietic stem cell tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenovirus Infection
• Cytomegalovirus Infection
• Epstein-barr Virus Infection

Drugs mentioned

• Antiviral cellular therapy for T-cell reconstitution (donor-derived virus-specific T cells) (virus-specific T cells)

Snippet

Sponsor: Pediatric Transplantation & Cellular Therapy Consortium | Conditions: Cytomegalovirus Infections, Adenovirus Infection | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING